<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-TAM25391-PKP-WK-LTW"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 S1305 IS: Agility in Manufacturing Preparedness Act of 2025</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2025-04-04</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>119th CONGRESS</congress><session>1st Session</session><legis-num>S. 1305</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20250404">April 4, 2025</action-date><action-desc><sponsor name-id="S384">Mr. Tillis</sponsor> (for himself and <cosponsor name-id="S337">Mr. Coons</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To allow for greater collaboration between the Biomedical Advanced Research and Development Authority and the network of Manufacturing USA institutes.</official-title></form><legis-body display-enacting-clause="yes-display-enacting-clause"><section section-type="section-one" id="S1"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Agility in Manufacturing Preparedness Act of 2025</short-title></quote>.</text></section><section commented="no" display-inline="no-display-inline" id="id58a3e205de5f4e65a7226cb6a72b7052"><enum>2.</enum><header>Increasing BARDA strategic initiatives</header><text display-inline="no-display-inline">Section 319L(c)(4)(F) of the Public Health Service Act (42 U.S.C. 247d–7e(c)(4)(F)) is amended—</text><paragraph commented="no" display-inline="no-display-inline" id="idaecc8e7c02874098ad8222d93c554088"><enum>(1)</enum><text display-inline="yes-display-inline">in the second sentence, in the matter preceding clause (i), by inserting <quote>, manufacturing technologies, platforms,</quote> after <quote>countermeasures</quote>; and</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="id6040ce0193ea4a728e4f8839bd9df16f"><enum>(2)</enum><text display-inline="yes-display-inline">by inserting after the first sentence the following: <quote>Such strategic coordination may include collaborating with the network of Manufacturing USA institutes established under section 34 of the National Institute of Standards and Technology Act in biomanufacturing missions to develop, demonstrate, and deploy technologies and response capabilities to improve public health and medical preparedness.</quote>.</text></paragraph></section></legis-body></bill> 

